Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > BCRX > Summary

BioCryst Pharmaceuticals, Inc.
(BCRX)

6.25USD   Down 0.30 (4.58%)   
At 2:30AM IST
 BioCryst Pharmaceuticals, Inc. (NGM:BCRX) Delayed quote data 
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Last Trade: 6.25USD
Trade Time:2:30AM IST
Change:Down 0.30 (4.58%) 
Prev Close:6.55
Open:6.66
Bid:5.56 x 100
Ask:N/A
1y Target Est:15.00
Day's Range:6.21 - 6.71
52wk Range:1.15 - 13.47
Volume:1,006,382
Avg Vol (3m):1,730,510
Market Cap:242.64M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A%)
Add BCRX to Portfolio   Download Data

HEADLINES

 
•Traders Send Select Stem Cell Shares Soaring - Indie Research  - Mon, Feb 8
•New Star Analyst Rankings for BioCryst Pharmaceuticals, Inc. - StarMine  - Sat, Feb 6
•Big Pharma's Shot In The Arm - CNBC  - Sat, Feb 6
•BioCryst Pharmaceuticals, Inc. Q4 2009 Earnings Call Transcript - Seeking Alpha  - Fri, Feb 5
•BioCryst 4Q profit rises on flu drug sales - AP  - Thu, Feb 4
•Swine Flu Antiviral Helps BioCryst Crush Estimates in Q4 - Indie Research  - Thu, Feb 4
•BIOCRYST PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition - EDGAR Online  - Thu, Feb 4
•UPDATE - BioCryst Q4 results top Street on flu drug sales - Reuters  - Thu, Feb 4
•Q4 2009 BioCryst Pharmaceuticals Earnings Release - Time Not Supplied - CCBN  - Thu, Feb 4
•BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update - PR Newswire  - Thu, Feb 4
» More Headlines for BCRX...

ANALYST

 
EPS Est (next year) (Dec-09) :-0.78
EPS Est (in 2 years) (Dec-10) :0.02
Avg Rec (current)*:2.8
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
BioCryst Pharmaceuticals, Inc. designs, optimizes, and develops small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer, and inflammatory diseases.

» Full Company Profile